Advertisement

Topics

QIAGEN's QuantiFERON-TB Gold Plus Gains Endorsement for Latent Tuberculosis Screening in Immigration

06:02 EDT 14 Mar 2018 | FinanzNachrichten

International Panel Physicians Association selects QFT-Plus for its proven value in diagnosing latent TB infection QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that its ...

Original Article: QIAGEN's QuantiFERON-TB Gold Plus Gains Endorsement for Latent Tuberculosis Screening in Immigration

NEXT ARTICLE

More From BioPortfolio on "QIAGEN's QuantiFERON-TB Gold Plus Gains Endorsement for Latent Tuberculosis Screening in Immigration"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...